Article by Brendan Bures, Fresh Toast
Just how will the coronavirus epidemic end? It’s a question you’ve probably wondered about multiple times during this period of quarantine and social distancing. If not, you likely wish things would just go back to normal. According to experts, one way the outbreak could end is doctors developing medications that prevent and/or treat the infection.
One medical supplier recently asked Health Canada for approval to study the effects of cannabis on COVID-19 patients. Dr. Mohan Cooray, who serves as president and CEO of Cannalogue, an online medical cannabis retailer in Toronto, wants to examine if certain cannabinoids can reduce inflammation and potential boost immune systems in a formal, rigorous setting.
“What we know from medical cannabis over the course of the literature and the experience we’ve had in Canada over the years is that there are known anti-inflammatory properties that cannabinoids have—cannabinoids being the active ingredients that come from the cannabis plant,” Dr. Cooray told The Toronto Sun.
Previous studies have shown that marijuana’s entourage effect — when whole-plant cannabinoids like THC, CBD, or CBG work in unison, instead of isolated doses like you find in CBD oil — demonstrates particular effectiveness in reducing inflammation. Other research has shown flavonoids in cannabis — the genes responsible for a plant’s color and pigmentation — contain anti-inflammatory effects 30 times more powerful than aspirin.
Dr. Cooray believes now is the time to build upon that research.